Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Determine if elevation in NLR associates with greater weight loss, cachexia and lower vitamin D concentrations in advanced cancer patients
Source: Associations between NLR symptoms and toxicities. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Systematic review.
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Associations between inflammatory biomarkers, symptoms, treatment toxicities and quality of life in people with advanced cancer receiving systemic anti-cancer treatments: a systematic review
Source: Article title.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Associations between inflammatory biomarkers, symptoms, treatment toxicities and quality of life in people with advanced cancer receiving systemic anti-cancer treatments: a systematic review
Systematic review · Supportive Care in Cancer · 2026
Original publication title
Associations between inflammatory biomarkers, symptoms, treatment toxicities and quality of life in people with advanced cancer receiving systemic anti-cancer treatments: a systematic review
© Crown 2026
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Examine the quality of evidence relating to the association of routine inflammatory biomarkers neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and monocyte-lymphocyte ratio (MLR) with symptoms, treatment toxicities, and quality of life (QoL) in people with advanced cancer.
Source: PurposeAbstract: What methods does the paper describe?
Searches were conducted in MEDLINE, Embase, CINAHL and the Cochrane database to identify studies that investigated associations between NLR, PLR and MLR with symptoms, toxicities and QoL in people with advanced cancer. The evidence was graded as good, fair or poor through the application of the National Institute of Health (NIH) quality assessment tool. A narrative approach was used for data synthesis.
Source: MethodsAbstract: Results
Of the 38 studies reviewed, NLR was the most frequently investigated biomarker. Thirteen studies found no association between NLR and symptoms or treatment toxicities. Of the 25 that did, five provided good quality evidence linking NLR to immune-related adverse events (irAEs), chemotherapy-related haematological toxicities and insufficient oral intake. However, NLR cut-off values varied across studies. Ten studies reported an association between PLR and symptoms or treatment toxicities whilst six studies found no associations; one study found no association with MLR and symptoms or treatment toxicities.
Source: ResultsAbstract: Conclusion
Further research is needed to establish specific cut-off values of NLR to increase the utility of this biomarker in clinical practice. PLR and MLR warrant further investigation for association with symptoms, treatment toxicities and QoL.
Source: ConclusionAuthors’ abstract
Purpose
Examine the quality of evidence relating to the association of routine inflammatory biomarkers neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and monocyte-lymphocyte ratio (MLR) with symptoms, treatment toxicities, and quality of life (QoL) in people with advanced cancer.
Methods
Searches were conducted in MEDLINE, Embase, CINAHL and the Cochrane database to identify studies that investigated associations between NLR, PLR and MLR with symptoms, toxicities and QoL in people with advanced cancer. The evidence was graded as good, fair or poor through the application of the National Institute of Health (NIH) quality assessment tool. A narrative approach was used for data synthesis.
Results
Of the 38 studies reviewed, NLR was the most frequently investigated biomarker. Thirteen studies found no association between NLR and symptoms or treatment toxicities. Of the 25 that did, five provided good quality evidence linking NLR to immune-related adverse events (irAEs), chemotherapy-related haematological toxicities and insufficient oral intake. However, NLR cut-off values varied across studies. Ten studies reported an association between PLR and symptoms or treatment toxicities whilst six studies found no associations; one study found no association with MLR and symptoms or treatment toxicities.
Conclusion
Further research is needed to establish specific cut-off values of NLR to increase the utility of this biomarker in clinical practice. PLR and MLR warrant further investigation for association with symptoms, treatment toxicities and QoL.
Publication and source details
Original title: Associations between inflammatory biomarkers, symptoms, treatment toxicities and quality of life in people with advanced cancer receiving systemic anti-cancer treatments: a systematic review
Helen Andersen; Wei-Hong Liu; Patsy Yates; Morgan J. Farley; Kim E. Alexander
Supportive Care in Cancer · 2026
© Crown 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Queensland University of TechnologyOpen Access funding enabled and organized by CAUL and its Member Institutions
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T22:12:39.955684+00:00
DOI: 10.1007/s00520-026-10922-5 · PMC13319193